Company intelligence
Ascendis Pharma
Committed to making a meaningful difference for patients
About Ascendis Pharma
Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.
Verified activity
Signals from Ascendis Pharma
5 published signals
Presence & Recognition
Ascendis Pharma presented sentinel data from the reACHin Trial for the treatment of infants with achondroplasia at the ESPE 2026 conference on Tuesday, September 8.
Reported by Ascendis Pharma
Presence & Recognition
Ascendis Pharma is hosting a symposium on achondroplasia at ESPE2026 in Les Goudes 2 on Tuesday, September 8 from 18:15 to 19:45.
Reported by Ascendis Pharma
Presence & Recognition
Ascendis Pharma is attending the Annual Meeting of the European Society for Paediatric Endocrinology in Marseille.
Reported by Ascendis Pharma
Presence & Recognition
Ascendis Pharma attended the International Skeletal Dysplasia Society Meeting in Toronto to participate in meaningful conversations with HCPs and industry partners.
Reported by Ascendis Pharma
People
Ascendis Pharma is hiring a new IT Lab Administrator for its Research Site in Heidelberg, Germany.
Reported by Ivanna Rosendal Oshida